Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome
Studies have been conducted to assess the effectiveness of Arbidol® in relation to the experimental form of severe acute respiratory syndrome in Syrian Golden hamster. It is shown that Arbidol® is most effective when used in therapeutic and prophylactic schemes. The coefficient of therapeutic action...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2020-05-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/150 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839591275082285056 |
---|---|
author | S. Ya. Loginova V. N. Shchukina S. V. Borisevich R. A. Khamitov V. A. Maksimov A. M. Shuster |
author_facet | S. Ya. Loginova V. N. Shchukina S. V. Borisevich R. A. Khamitov V. A. Maksimov A. M. Shuster |
author_sort | S. Ya. Loginova |
collection | DOAJ |
description | Studies have been conducted to assess the effectiveness of Arbidol® in relation to the experimental form of severe acute respiratory syndrome in Syrian Golden hamster. It is shown that Arbidol® is most effective when used in therapeutic and prophylactic schemes. The coefficient of therapeutic action for virological, hematological and biochemical parameters was 57.5 and 65.0%, respectively (P |
format | Article |
id | doaj-art-2e5ce733f52c4069be1a069cf5b95ef6 |
institution | Matheson Library |
issn | 0235-2990 |
language | Russian |
publishDate | 2020-05-01 |
publisher | LLC "Publishing House OKI" |
record_format | Article |
series | Антибиотики и Химиотерапия |
spelling | doaj-art-2e5ce733f52c4069be1a069cf5b95ef62025-08-03T13:04:43ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01647-8192310.24411/0235-2990-2019-100039149Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory SyndromeS. Ya. Loginova0V. N. Shchukina1S. V. Borisevich2R. A. Khamitov3V. A. Maksimov4A. M. Shuster548th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation48th Central Scientific Research Institute of the Ministry of Defense of the Russian FederationOOO International Biotechnology Center «Generium»48th Central Scientific Research Institute of the Ministry of Defense of the Russian FederationOOO International Biotechnology Center «Generium»; Moscow OAO «Pharmstandard»Studies have been conducted to assess the effectiveness of Arbidol® in relation to the experimental form of severe acute respiratory syndrome in Syrian Golden hamster. It is shown that Arbidol® is most effective when used in therapeutic and prophylactic schemes. The coefficient of therapeutic action for virological, hematological and biochemical parameters was 57.5 and 65.0%, respectively (Phttps://www.antibiotics-chemotherapy.ru/jour/article/view/150arbidol®severe acute respiratory syndromepreventioncoefficient of therapeutic action |
spellingShingle | S. Ya. Loginova V. N. Shchukina S. V. Borisevich R. A. Khamitov V. A. Maksimov A. M. Shuster Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome Антибиотики и Химиотерапия arbidol® severe acute respiratory syndrome prevention coefficient of therapeutic action |
title | Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome |
title_full | Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome |
title_fullStr | Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome |
title_full_unstemmed | Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome |
title_short | Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome |
title_sort | analysis of arbidol r effectiveness agains an experimental form of severe acute respiratory syndrome |
topic | arbidol® severe acute respiratory syndrome prevention coefficient of therapeutic action |
url | https://www.antibiotics-chemotherapy.ru/jour/article/view/150 |
work_keys_str_mv | AT syaloginova analysisofarbidoleffectivenessagainsanexperimentalformofsevereacuterespiratorysyndrome AT vnshchukina analysisofarbidoleffectivenessagainsanexperimentalformofsevereacuterespiratorysyndrome AT svborisevich analysisofarbidoleffectivenessagainsanexperimentalformofsevereacuterespiratorysyndrome AT rakhamitov analysisofarbidoleffectivenessagainsanexperimentalformofsevereacuterespiratorysyndrome AT vamaksimov analysisofarbidoleffectivenessagainsanexperimentalformofsevereacuterespiratorysyndrome AT amshuster analysisofarbidoleffectivenessagainsanexperimentalformofsevereacuterespiratorysyndrome |